We are live on ! Find out more
HOOK

HOOKIPA Pharma

Delisted

HOOK was delisted on the 7th of August, 2025.

33 hedge funds and large institutions have $44.1M invested in HOOKIPA Pharma in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.03% more ownership

Funds ownership: 0%3.03% (+3%)

Holders
33
Holders Change
+33
Holders Change %
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
33
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

HOOK Hedge Fund Activity: Q2 2019 in Review

33 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q2 2019, worth a combined $44.1M.

Buyers outnumbered sellers: 33 funds opened new HOOK positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $20.1M.

  • 33 institutional investors held HOOKIPA Pharma (HOOK) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $44.1M of HOOKIPA Pharma stock for Q2 2019.
  • 33 funds opened new HOOKIPA Pharma positions in Q2 2019 and 0 closed out, a net change of +33 holders.
  • The largest HOOKIPA Pharma buyer in Q2 2019 was Redmile Group, an estimated $20.1M added.

Based on aggregated 13F filings for Q2 2019.